The grant, decoded. On June 2, 2026, MatrixSpace, Inc. was granted US12644983B2, "Methods for improving radar angular resolution by moving nodes in response to a projected target path." The clever idea: instead of building a bigger, more expensive fixed radar to get finer angular resolution, you move the sensing nodes intelligently as the target moves, synthesizing better resolution from cheaper hardware. The classifications sit in the G01S 13/933 radar family.
Cheaper hardware that performs like expensive hardware is, fundamentally, a market-expansion move. It lets the same product address customers who could never afford a traditional high-end radar — which is the essence of the dual-use bet: serve defense surveillance, counter-drone, and commercial airspace-awareness buyers from one engineering base.
Here is where the Concentration Risk lens comes in. Dual-use sounds like diversification, but in practice early-stage sensor companies usually get their revenue concentrated in one customer type — typically defense, because defense pays first and pays for capability. That concentration cuts both ways: it funds the company through the hard early years, and it makes the company hostage to a single budget cycle or program decision.
The disclosure-driven caveat: MatrixSpace is private, so there is no government-revenue-concentration percentage to cite, and we will not manufacture one. What the patent tells us is the intended breadth of the market; what it cannot tell us is how concentrated the actual revenue is. Those are different questions, and conflating them is the error this beat exists to avoid.
The takeaway for an analyst: a moving-node radar patent is a credible attempt to turn a defense-grade capability into a broad commercial product. Whether that breadth materializes — or whether the company stays a single-customer defense supplier in practice — is the concentration question that determines the risk profile. The patent sets the ambition; only the eventual financials, where disclosed, settle the reality.